These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10229684)

  • 1. Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
    Howlett DR; Perry AE; Godfrey F; Swatton JE; Jennings KH; Spitzfaden C; Wadsworth H; Wood SJ; Markwell RE
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):283-9. PubMed ID: 10229684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?
    Hartsel SC; Weiland TR
    Biochemistry; 2003 May; 42(20):6228-33. PubMed ID: 12755626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity.
    Rizzo S; Rivière C; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Morroni F; Tarozzi A; Monti JP; Rampa A
    J Med Chem; 2008 May; 51(10):2883-6. PubMed ID: 18419109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A beta fibrillogenesis: kinetic parameters for fibril formation from congo red binding.
    Inouye H; Kirschner DA
    J Struct Biol; 2000 Jun; 130(2-3):123-9. PubMed ID: 10940220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detergent-like interaction of Congo red with the amyloid beta peptide.
    Lendel C; Bolognesi B; Wahlström A; Dobson CM; Gräslund A
    Biochemistry; 2010 Feb; 49(7):1358-60. PubMed ID: 20070125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
    Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological development of beta(1-40) amyloid fibrils.
    Blackley HK; Patel N; Davies MC; Roberts CJ; Tendler SJ; Wilkinson MJ; Williams PM
    Exp Neurol; 1999 Aug; 158(2):437-43. PubMed ID: 10415150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
    Ohnishi S; Koide A; Koide S
    J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.
    Byun JH; Kim H; Kim Y; Mook-Jung I; Kim DJ; Lee WK; Yoo KH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5591-3. PubMed ID: 18793854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dendrimer's structure on its activity against amyloid fibril formation.
    Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
    Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of beta-amyloid fibril elongation.
    Cannon MJ; Williams AD; Wetzel R; Myszka DG
    Anal Biochem; 2004 May; 328(1):67-75. PubMed ID: 15081909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol derivatives inhibit the fibril formation of amyloid-beta peptides.
    Huong VT; Shimanouchi T; Shimauchi N; Yagi H; Umakoshi H; Goto Y; Kuboi R
    J Biosci Bioeng; 2010 Jun; 109(6):629-34. PubMed ID: 20471605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple ligand binding sites on A beta(1-40) fibrils.
    LeVine H
    Amyloid; 2005 Mar; 12(1):5-14. PubMed ID: 16076606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors.
    Goldsbury CS; Wirtz S; Müller SA; Sunderji S; Wicki P; Aebi U; Frey P
    J Struct Biol; 2000 Jun; 130(2-3):217-31. PubMed ID: 10940227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations.
    Wu C; Wang Z; Lei H; Zhang W; Duan Y
    J Am Chem Soc; 2007 Feb; 129(5):1225-32. PubMed ID: 17263405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions.
    Porat Y; Mazor Y; Efrat S; Gazit E
    Biochemistry; 2004 Nov; 43(45):14454-62. PubMed ID: 15533050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta (1-42) folding multiplicity and single-molecule binding behavior studied with STM.
    Ma X; Liu L; Mao X; Niu L; Deng K; Wu W; Li Y; Yang Y; Wang C
    J Mol Biol; 2009 May; 388(4):894-901. PubMed ID: 19328210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
    Danielsson J; Pierattelli R; Banci L; Gräslund A
    FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.